EU pharmacovigilance legislation implementation likely to be staggered
This article was originally published in SRA
Executive Summary
The European Medicines Agency is unlikely to meet all its requirements under the far reaching pharmacovigilance legislation by the original implementation deadline of July 2012. Instead, the agency will implement the legislation in phases, beyond the deadline, Peter Arlett, head of pharmacovigilance and risk management at the EMA, has said.